Alector reports 2021 first quarter financial results and provides business update

South san francisco, calif., may 05, 2021 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced business updates and financial results for the first quarter ended march 31, 2021.
ALEC Ratings Summary
ALEC Quant Ranking